LONDON, Dec. 20, 2012 /PRNewswire/ -- The European patient temperature management systems market is currently in a growth phase due to increased awareness about the benefits of patient temperature management, as well as the availability of different products in the marketplace. The market is dynamic and is expected to witness strong growth in the next 5 years.
New analysis from Frost & Sullivan (http://www.healthcare.frost.com), Western European Patient Temperature Management Market, finds that the market generated $ 556.5 million in 2011 and estimates this to reach $ 903.2 million in 2018. The research covers blood and fluid warmers, convective warming devices, invasive warming and cooling devices and surface warming and cooling devices.
The patient warming systems segment has witnessed steady growth over the last 2 years due to recommendations made by healthcare bodies such as the National Health Service (NHS) in the United Kingdom. Nationally recommended guidelines now counsel patient warming devices for pre-operative, peri-operative and post-operative phases.
"National guidelines issued by healthcare governing bodies are suggesting the use of patient warming devices to minimise inadvertent peri-operative hypothermia," explains Frost & Sullivan Healthcare Analyst Brahadeesh Chandrasekaran. "One of the recommendations made by the Guideline Development Group to the National Institute of Health and Clinical Excellence (NICE) in the United Kingdom has been to use patient warming devices during the intra-operative phase."
At the same time, many research studies are highlighting the benefits of induced hypothermia in patients undergoing cardiac, brain and spinal surgery. This is set to spur demand for patient cooling devices.
Despite the implementation of guidelines and increasing clinical evidence supporting the use of warming and cooling devices, adoption by healthcare professionals continues to lag.
"Low adoption levels are due to a lack of confidence among trained professionals who are diffident about using these technologically sophisticated products across various surgical procedures," notes Chandrasekaran. "Manufacturers need to focus on making their products more accessible and user-friendly."
The market is highly dynamic and competitive with high growth potential projected over the next 3 to 5 years. Keen to leverage this growth, large medical device companies have already entered and strengthened their product lines. The market has also already witnessed 5 major acquisitions in the last 2 years, and this mergers and acquisitions trend is set to continue.
"There is no clear market leader with a dominant share in all 4 segments," concludes Chandrasekaran. "Companies are, therefore, seeking to gain a competitive edge through strategic alliances and acquisitions that will allow them to develop a comprehensive product portfolio."
If you are interested in more information on this study, please send an email with your contact details to Anna Zanchi, Corporate Communications, at email@example.com.
Western European Patient Temperature Management Market is part of the Advanced Medical Technologies Growth Partnership Service programme, which also includes research in the following markets: Cardiac Rhythm Management, Tissue Sealants and Haemostats and Compression Therapy Devices. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
SOURCE Frost & Sullivan